@inproceedings{inproceedings, title  = {{Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart® Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) Patients}},

 publisher = {{American Society of Hematology}},

 url = {{https://doi.org/10.1182/blood-2019-122073 }},

 year = {{2019}},

 month = {{11}},

 author = {{Uy GL and Aldoss I and Foster MC and Sallman DA and Sweet KL and Rizzieri DA and Sayre PH and Advani AS and Emadi A and Wieduwilt MJ and Vey N et al}},

 doi = {{10.1182/blood-2019-122073}},

 volume = {{134}},

 journal = {{Blood}},

 issue = {{Supplement_1}},

 pages = {{733-733}},

 note = {{Accessed on 2026/02/25}}}